Document Detail

Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.
MedLine Citation:
PMID:  22915644     Owner:  NLM     Status:  MEDLINE    
Coronary heart disease is a major cause of death in the western world. Although essential for successful recovery, reperfusion of ischemic myocardium is inevitably associated with reperfusion injury. To investigate a potential protective role of ADAMTS13, a protease cleaving von Willebrand factor multimers, during myocardial ischemia/reperfusion, we used a mouse model of acute myocardial infarction. We found that Adamts13(-/-) mice developed larger myocardial infarctions than wild-type control mice, whereas treatment of wild-type mice with recombinant human ADAMTS13 (rhADAMTS13) led to smaller infarctions. The protective effect of ADAMTS13 was further confirmed by a significant reduction of cardiac troponin-I release and less myocardial apoptosis in mice that received rhADAMTS13 compared with controls. Platelets adherent to the blood vessel wall were observed in few areas in the heart samples from mice treated with vehicle and were not detected in samples from mice treated with rhADAMTS13. However, we observed a 9-fold reduction in number of neutrophils infiltrating ischemic myocardium in mice that were treated with rhADAMTS13, suggesting a potent anti-inflammatory effect of ADAMTS13 during heart injury. Our data show that ADAMTS13 reduces myocardial ischemia/reperfusion injury in mice and indicate that rhADAMTS13 could be of therapeutic value to limit myocardial ischemia/reperfusion injury.
Simon F De Meyer; Alexander S Savchenko; Michael S Haas; Daphne Schatzberg; Michael C Carroll; Alexandra Schiviz; Barbara Dietrich; Hanspeter Rottensteiner; Friedrich Scheiflinger; Denisa D Wagner
Related Documents :
9562004 - Transient ischemia does not limit subsequent ischemic regional dysfunction in humans: a...
22172784 - Detection and quantification of myocardial reperfusion hemorrhage using t2*-weighted cmr.
19844104 - Investigation of the alterations in cellular electrophysiology underlying ventricular a...
8813544 - Effects of a new endothelin receptor antagonist, tak-044, on myocardial stunning in dogs.
10720584 - Angiotensin ii type 1 receptor a1166c gene polymorphism is associated with an increased...
16632594 - Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac r...
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-08-22
Journal Detail:
Title:  Blood     Volume:  120     ISSN:  1528-0020     ISO Abbreviation:  Blood     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-21     Completed Date:  2013-02-15     Revised Date:  2014-01-09    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5217-23     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
ADAM Proteins / adverse effects,  pharmacokinetics,  pharmacology*,  therapeutic use
Anti-Inflammatory Agents / adverse effects,  pharmacokinetics,  pharmacology*
CHO Cells
Cardiotonic Agents / adverse effects,  pharmacokinetics,  pharmacology*
Cytoprotection / drug effects*,  genetics
Metalloendopeptidases / genetics,  metabolism,  physiology
Mice, Inbred C57BL
Mice, Knockout
Myocardial Reperfusion Injury / drug therapy,  genetics,  metabolism,  prevention & control*
Recombinant Proteins / adverse effects,  pharmacokinetics,  pharmacology,  therapeutic use
Grant Support
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Cardiotonic Agents; 0/Recombinant Proteins; EC 3.4.24.-/ADAM Proteins; EC 3.4.24.-/ADAMTS13 protein, human; EC 3.4.24.-/ADAMTS13 protein, mouse; EC 3.4.24.-/Metalloendopeptidases
Comment In:
Blood. 2012 Dec 20;120(26):5096-7   [PMID:  23258899 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Impact of hydroxyurea on clinical events in the BABY HUG trial.
Next Document:  The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase dependent cleavage of calr...